News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on EMvision Medical Devices.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Hold the front page for a rush of clinical trial updates
Health & Biotech
Health Check: Rats – and investors – are happy as Nyrada forges ahead with its first human trial
Health & Biotech
Dr Boreham’s Crucible: A stroke-scanning player targeting unmet medical need and a massive market
News
ASX Small Caps Lunch Wrap: We’re not angry. Just… disappointed after a midweek sag
Health & Biotech
Curvebeam’s “weight-bearing CT scanner” to gain more traction after FDA clearance
Health & Biotech
ASX Health Stocks: Focus on retina-disease drug study draws eyes
Health & Biotech
ASX Health Stocks: Proteomics to start selling in France; Recce to start clinical trials
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Rare earths hit launches 300pc small cap moon shot, as ASX benchmark beards its bears
Health & Biotech
ASX Health Stocks: EMV’s AI algo shows promise, and Telix submits new FDA application
News
Market Highlights: ASX to rebound after US survey; and 5 ASX small caps to watch today
Health & Biotech
ASX Health Stocks: EMV gets strategic US$15m investment from NYSE-listed giant
News
Market Highlights: New record in sight for Bitcoin, and 5 ASX small caps to watch on Thursday
Health & Biotech
Check Up: Introducing the Brain Atlas, the largest map of the human brain. And recent ASX biotech winners
Health & Biotech
ASX Health Stocks: EMvision calls its AI brain scanner ’emu’
Health & Biotech
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads
Health & Biotech
